Fundraising FoxForesite Capital — 2020 Investments
7 investments dated 2020 · listed companies and verified rows first · show all
bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications.
BiotechDeep TechHealthtechMedical Devices
Dr Mark Kotter(Founder)Przemek Obloj(CEO)inEmma Pepperell(CEO)inMark Kotter(Founder)
Co-investorsBlueYard CapitalARCH Venture PartnersDynamk CapitalGood AI CapitalHarmonix FundHAWKTAIL+8 more
Everlywell offers at-home lab testing kits and virtual healthcare services across multiple wellness categories including daily health screening, digestive analysis, sexual health testing, and hormone monitoring.
ConsumerDigital HealthHealthtechWellness & Fitness
Julia Cheek(Founder & CEO)in
Co-investorsAnsa CapitalBreyer CapitalCerity Partners VenturesHalogen Ventures Management Company LlcLux CapitalNext Coast Ventures+12 more
Co-investorsCivilization Ventures Management, LlcDCVC (Data Collective)Molten VenturesRising TideStart Capital
insitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines.
AI & Machine LearningBiotechSouth San Francisco, US
Daphne Koller(Founder)inDuane Valz(General Counsel)inMary Rozenman(Chief Financial Officer)in
BoardRobert Nelsen(Director)Vijay Pande(Director)in
Co-investorsAndreessen HorowitzARCH Venture PartnersDeviation CapitalGV (Google Ventures)HOF CapitalSoftBank Vision Fund+9 more
Lyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology.
BiotechDeep TechHealthtechMedical DevicesBothell, US
Stan Riddell(Executive Officer)Richard Klausner(Executive Officer, Director, Promoter)Stephen Hill(Executive Officer)inHeather Turner(Executive Officer)inRichard Goold(Executive Officer)inMargo Roberts(Executive Officer)
Co-investorsARCH Venture PartnersvenBio Partners8VCAxial VC
Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
BiotechDeep TechMedical DevicesBrisbane, US
Jennifer Doudna(Founder)inTrevor Martin(Founder)inJanice Chen(Founder)inLucas Harrington(Founder)inAshley Tehranchi(Founder)in
BoardUrshit Parikh(Director)
Co-investors8VCAlephBerkeley FrontierCalifornia Innovation FundDecheng CapitalK50 Ventures+13 more
SomaLogic develops proteomics tools that help researchers measure protein function and study human biology across a range of scientific applications.
BiotechDeep TechHealthtechBoulder, US
Larry Gold(Founder)inDaniel Muehl(Executive Officer)Byron Hewett(Executive Officer, Director)in
BoardCharles Lillis(Director)Youichi Yabuuchi(Director)Terry Randall(Director)
Co-investorsKhosla VenturesCasdin CapitalMagnetar CapitalReimagined VenturesSoleus CapitalT. Rowe Price
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.